Home | Welcome to Contract Pharma   
Last Updated Saturday, May 18 2013
Print

Industry News

Related Searches:

Filter by:

January 23, 2008
AAIPharma's sterile manufacturing plant in Charleston, SC received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to produce aseptic and lyophilized products. The approval follows a $1.5 million renovation of the plant a…   Read More »
January 22, 2008
Teva Pharmaceutical Industries Ltd. has entered into a definitive agreement to acquire CoGenesys, Inc. for $400 million cash. CoGenesys is a biopharmaceutical company focused on the development of peptide- and protein-based medicines. CoGenesys was e…   Read More »
January 18, 2008
Quintiles Transnational Corp. will open an office in Wilmington, NC, expanding the company's clinical research in pharmaceutical and biotechnology development. The company opened a data processing center in Williamston, NC last January.   …   Read More »
January 18, 2008
QLT, Inc. has restructured, eliminating 45% of its workforce -- approximately 115 people -- at its Vancouver headquarters and its U.S. subsidiaries, including members of its management team.     The reduction in staff is part of the…   Read More »
January 17, 2008
Talecris Biotherapeutics, Inc. (TBI) announced the merger of Precision Pharma Services, a wholly-owned subsidiary of Talecris, into TBI. Talecris’ parent company acquired Precision Pharma of Melville, NY in 2005, maintaining its name and separa…   Read More »
January 16, 2008
Sartorius Stedim Biotech’s subsidiary, Sartorius Stedim North America, has entered into an exclusive cooperation and supply agreement with Paul Mueller Co. (PMC), covering the U.S., Canada, the U.S. Virgin Islands and Puerto Rico. Sartorius Ste…   Read More »
January 16, 2008
Akrimax Pharmaceuticals has acquired Wyeth's drug product manufacturing and packaging plant in Rouses Point, NY. In late 2005, Wyeth announced plans to phase out operations at the Rouses Point plant due to changes in product demand and restructuring…   Read More »
January 15, 2008
SAFC, a member of the Sigma-Aldrich group, has plans for a $12 million expansion at its biologics production facility in Carlsbad, CA. Two new, separate state-of-the-art viral product manufacturing suites will employ the latest in disposable bioreact…   Read More »
January 14, 2008
Merck has signed a licensing agreement for an authorized generic form of its osteoporosis drug, Fosamax, which will be available after the U.S. patent expires in February 2007. The drug's global annual sales are approximately $3 billion.   …   Read More »
January 11, 2008
The Association of Clinical Research Organizations (ACRO), which represents the clinical outsourcing industry to regulators in the U.S. and worldwide, biopharmaceutical clients, policy makers and the public, recently elected new officers for 2008. &…   Read More »
January 11, 2008
Benda Pharmaceutical, Inc., a China-based company that produces Gendicine, a commercialized gene therapy drug for the treatment of cancer, received GMP certification at its newly expanded Ebei plant for its new tablets product line. The GMP certifica…   Read More »
January 10, 2008
Quintiles Transnational Corp. has expanded and consolidated its Global Central Laboratories and Clinical Development Services (CDS) units in Beijing, China. The new consolidated facility in China has more than 17,000 sq. ft. of space and is loca…   Read More »
January 10, 2008
Bosch Packaging Technology opened its new state-of-the-art manufacturing facility in Verna Industrial Estate in Goa, India. The 2,600-square-meter facility produces and assembles packaging technology equipment for packing vials, ampoules and syringes…   Read More »
January 9, 2008
Wyeth has entered an agreement to purchase the global rights to develop and market an experimental pain medication from Mochida Pharmaceutical Co. Ltd., the Japanese company said on Wednesday. Financial terms were not disclosed. The drug candi…   Read More »
January 8, 2008
PII (Pharmaceutics International, Inc.) has acquired Pharmaterials Ltd., a preformulation and formulation development company based in Reading, UK. The acquisition extends PII's business development initiatives and service offerings. Steve King,…   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On